News | May 29, 2023
Wockhardt’s Q4 FY23 three fold jump in EBITDA over Q4 FY22
Two patents were filed during the quarter ended 31st March, 2023 and the cumulative filings till date are 3239
Two patents were filed during the quarter ended 31st March, 2023 and the cumulative filings till date are 3239
The company has reported total income of Rs. 604.02 crores during the period ended March 31, 2023
Mandaviya felicitated voluntary blood donors and states/UTs that have done exemplary work
Despite the technological advancements, there remains no alternative to blood and one unit of blood can save as many as three lives
The CSC shall hold Market Authorisation (MA) to sell SRL's BUSALFAN, API exclusively in China territory.
This includes USD 100 million to advance R&D of its neglected tropical disease program, focusing on novel drug candidates for four diseases.
The unit is an oral manufacturing facility at Jedcherla, Hyderabad
Technology Development Board supports commercialisation of Metal Injection Molding of implants
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
Nureca Ltd has reported financial results for the period ended June 30, 2021.
Subscribe To Our Newsletter & Stay Updated
